News Review: Harmony Gold Mining Company Limited (NYSE:HMY), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)


Harmony Gold Mining Company Limited (NYSE:HMY)

Harmony Gold Mining Company Limited (NYSE:HMY) represented a move of -1.42 percent or $0.02 per share and closed its previous day trading session at $2.08. 2.06 Million Shares were traded in the last trading session with an Average Volume of 3.49 Million Shares. The stock currently has a Market Capitalization of 1.08 Billion.

Harmony Gold Mining Company Ltd. is a mining company which produces gold from its operations in the distrcit of Virginia, Orange Free State.

The stock traded between $1.42 and $2.53 over 1-Year time period showing its price to sales ratio of 0.77. Harmony Gold Mining Company Limited (NYSE:HMY) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $17.28 and 200-Day Simple Moving Average of $12.42. Its Price to Free Cash Flow is 0 and Price to Book of 0.45.

Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

In the last trading session, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) added its value by -6.36% closing at the price of $163.09. The stock currently has market capitalization of 42.44 Billion, with average volume of 1.19 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is showing beta of 1.59. This particular value of beta suggests that Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has historically moved 159% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is at $1.6.

The stock currently has RSI of 30.97. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) topped its 52-week high price of $194.92 on 10/01/18 and 52-Week Low Price of $136.50 on 12/07/17. The Stock currently has P/E (price to earnings ttm) of 102.19 and Weekly volatility of 4.94% and monthly volatility of 3.17% respectively.